These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 15790572)

  • 1. Engineering and functional immobilization of opioid receptors.
    Ott D; Neldner Y; Cèbe R; Dodevski I; Plückthun A
    Protein Eng Des Sel; 2005 Mar; 18(3):153-60. PubMed ID: 15790572
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Construction and characterization of a kappa opioid receptor devoid of all free cysteines.
    Ott D; Frischknecht R; Plückthun A
    Protein Eng Des Sel; 2004 Jan; 17(1):37-48. PubMed ID: 14985536
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The opioid ligand binding of human mu-opioid receptor is modulated by novel splice variants of the receptor.
    Choi HS; Kim CS; Hwang CK; Song KY; Wang W; Qiu Y; Law PY; Wei LN; Loh HH
    Biochem Biophys Res Commun; 2006 May; 343(4):1132-40. PubMed ID: 16580639
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hetero-oligomers of alpha2A-adrenergic and mu-opioid receptors do not lead to transactivation of G-proteins or altered endocytosis profiles.
    Zhang YQ; Limbird LE
    Biochem Soc Trans; 2004 Nov; 32(Pt 5):856-60. PubMed ID: 15494033
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transient overexpression of kappa and mu opioid receptors using recombinant adenovirus vectors.
    Zhen Z; Bradel-Tretheway BG; Dewhurst S; Bidlack JM
    J Neurosci Methods; 2004 Jul; 136(2):133-9. PubMed ID: 15183265
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Homology modeling and molecular dynamics simulations of the mu opioid receptor in a membrane-aqueous system.
    Zhang Y; Sham YY; Rajamani R; Gao J; Portoghese PS
    Chembiochem; 2005 May; 6(5):853-9. PubMed ID: 15776407
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design of high affinity cyclic pentapeptide ligands for kappa-opioid receptors.
    Przydzial MJ; Pogozheva ID; Ho JC; Bosse KE; Sawyer E; Traynor JR; Mosberg HI
    J Pept Res; 2005 Nov; 66(5):255-62. PubMed ID: 16218993
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of binding domain and function of chimeric mu/kappa opioid receptors to ohmefentanyl stereoisomers.
    Feng YP; Chen LW; Zhou DH; Chen J; Xu XJ; Chi ZQ
    Acta Pharmacol Sin; 2001 Nov; 22(11):981-5. PubMed ID: 11749787
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional complementation and the analysis of opioid receptor homodimerization.
    Pascal G; Milligan G
    Mol Pharmacol; 2005 Sep; 68(3):905-15. PubMed ID: 15967873
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antagonist efficacy in MORS196L mutant is affected by the interaction between transmembrane domains of the opioid receptor.
    Claude-Geppert PA; Liu J; Solberg J; Erickson-Herbrandson LJ; Loh HH; Law PY
    J Pharmacol Exp Ther; 2005 Apr; 313(1):216-26. PubMed ID: 15579496
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cloning, heterologous expression and pharmacological characterization of a kappa opioid receptor from the brain of the rough-skinned newt, Taricha granulosa.
    Bradford CS; Walthers EA; Searcy BT; Moore FL
    J Mol Endocrinol; 2005 Jun; 34(3):809-23. PubMed ID: 15956349
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Refinement of a homology model of the mu-opioid receptor using distance constraints from intrinsic and engineered zinc-binding sites.
    Fowler CB; Pogozheva ID; LeVine H; Mosberg HI
    Biochemistry; 2004 Jul; 43(27):8700-10. PubMed ID: 15236578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mu-delta opioid receptor functional interaction: Insight using receptor-G protein fusions.
    Snook LA; Milligan G; Kieffer BL; Massotte D
    J Pharmacol Exp Ther; 2006 Aug; 318(2):683-90. PubMed ID: 16690720
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of the extracellular amino terminus and first membrane-spanning helix of dopamine D1 and D5 receptors in shaping ligand selectivity and efficacy.
    D'Aoust JP; Tiberi M
    Cell Signal; 2010 Jan; 22(1):106-16. PubMed ID: 19786093
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional cartography of the ectodomain of the type I interferon receptor subunit ifnar1.
    Lamken P; Gavutis M; Peters I; Van der Heyden J; Uzé G; Piehler J
    J Mol Biol; 2005 Jul; 350(3):476-88. PubMed ID: 15946680
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Engineered G protein coupled receptors reveal independent regulation of internalization, desensitization and acute signaling.
    Scearce-Levie K; Lieberman MD; Elliott HH; Conklin BR
    BMC Biol; 2005 Feb; 3():3. PubMed ID: 15707483
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mu opioid receptor mutant, T394A, abolishes opioid-mediated adenylyl cyclase superactivation.
    Wang H; Guang W; Barbier E; Shapiro P; Wang JB
    Neuroreport; 2007 Dec; 18(18):1969-73. PubMed ID: 18007196
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Further studies of tyrosine surrogates in opioid receptor peptide ligands.
    Dolle RE; Michaut M; Martinez-Teipel B; Belanger S; Graczyk TM; DeHaven RN
    Bioorg Med Chem Lett; 2007 May; 17(9):2656-60. PubMed ID: 17350835
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diverse immunocytochemical expression of opioid receptors in electrophysiologically defined cells of rat dorsal root ganglia.
    Rau KK; Caudle RM; Cooper BY; Johnson RD
    J Chem Neuroanat; 2005 Jun; 29(4):255-64. PubMed ID: 15927787
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NMDAR-nNOS generated zinc recruits PKCgamma to the HINT1-RGS17 complex bound to the C terminus of Mu-opioid receptors.
    Rodríguez-Muñoz M; de la Torre-Madrid E; Sánchez-Blázquez P; Wang JB; Garzón J
    Cell Signal; 2008 Oct; 20(10):1855-64. PubMed ID: 18652891
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.